Association Between Administration of Dexmedetomidine & Postoperative

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The present multicentre retrospective cohort study aimed to investigate the association between intraoperative administration of dexmedetomidine and postoperative mortality in hospitals. The investigators set out to test the hypothesis that perioperative dexmedetomidine use, as an adjunct to general anesthesia, diminishes postoperative mortality in hospitals across all categories of surgical patients.

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT02599636` - To Survive After ICU Discharge	N/A

NCT number	NCT06248346
Study type	Observational
Source	Xijing Hospital
Contact
Status	Completed
Phase
Start date	September 1, 2014
Completion date	July 1, 2018

Association Between Administration of Dexmedetomidine and Postoperative Mortality in Hospitals

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms